A major clinical trial, which included 13 patients from National University Hospital, showed that the drug lecanemab slowed cognitive and functional decline in participants aged 50 to 90 with early Alzheimer’s disease.
In The Straits Times’ The Big Story, Multimedia Correspondent Cheow Sue-Ann speaks with Associate Professor Christopher Chen, a Visiting Consultant in the Department of Psychological Medicine at NUH about the research.

Wealth Tracker: Are commercial space programs poised to deliver returns for investors?
08:16

What’s Trending: A candle that brings back your ex..... and a kid got shoved at Shibuya?
16:57

The Big Story: Singapore’s fertility rate at new low. Can we reverse the baby bust before its too late?
11:42